Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Efficacy and Safety of Recombinant human thrombopoietin in patients with severe aplastic anemia and very severe aplastic anemia, a randomized, double-blind, placebo-controlled, II phase, multi-center clinical research.
Epistemonikos ID: 3eefe1abea109731e9611f2a71e11fa726a3f95e
First added on: May 17, 2024